Skip to content

Rita Santacroce

3 papers in the library · 331 citations · publishing 2014-2018

Papers

Sort Most recent Most cited

Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives

Brain Sciences March 16, 2018 Giovanni Martinotti, Rita Santacroce, Mauro Pettorruso et al. 171 citations

Hallucinogen Persisting Perception Disorder (HPPD) is a rare, and therefore, poorly understood condition linked to hallucinogenic drugs consumption. The prevalence of this disorder is low; the condition is more often diagnosed in individuals with a history of previous psychological issues or substance misuse, but it can arise in anyone, even after a single exposure to triggering drugs. The aims...

Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset

CNS & Neurological Disorders - Drug Targets April 17, 2017 Giovanni Martinotti, Rita Santacroce, Duccio Papanti et al. 62 citations

BACKGROUND: Synthetic Cannabinoids (SC) are the widest and most diffused class of Novel Psychoactive Substances. The short- and long- term health risks associated with the consumption of SC are often unknown to both users and health professionals. This review aims to provide a synthesis of the most recent and relevant insights on the pharmacology, clinical and psychopathological aspects of SC....

25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug

BioMed Research International 2014 Francesco Saverio Bersani, Ornella Corazza, Gabriella Albano et al. 98 citations

Introduction. The use of novel psychoactive substances (NPSs) has rapidly increased as well as their online availability. The aim of this paper is to provide a comprehensive review of the nature and the risks associated with 25C-NBOMe, which has recently appeared in the drug market. Methods. A systematic analysis of the scientific literature and a qualitative assessment of online and media...